This brand name is authorized in Cyprus.
The drug FLEELAXAT contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
E1W4N241FO - SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE
|
2
|
UNII
3980JIH2SW - SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A06AD | Osmotically acting laxatives | A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.